Susan C. Farrar LT MC USNR , Jon Yenari LCDR MC USNR , Robert B. Gherman CDR (sel) MC USNR
{"title":"Emergency contraception: a “fire extinguisher” for unintended pregnancies","authors":"Susan C. Farrar LT MC USNR , Jon Yenari LCDR MC USNR , Robert B. Gherman CDR (sel) MC USNR","doi":"10.1016/S1068-607X(03)00069-6","DOIUrl":null,"url":null,"abstract":"<div><p><span>The American College of Obstetricians and </span>Gynecologists<span><span><span><span> defines emergency contraception, also known as post-coital contraception and the “morning after pill,” as “a therapy for women who experience an act of unprotected sexual intercourse.” It has been estimated that post-coital contraception could reduce the number of unintended pregnancies by 2 million and the number of induced abortions by 1 million. Several methods of emergency contraception are widely accepted including an estrogen-progestin combination, </span>progestin<span><span> only, mifepristone (RU486), and the </span>copper intrauterine device (IUD). The major side effects of post-coital contraception include nausea, vomiting, and </span></span>menstrual cycle abnormalities. Currently, the biggest obstacles to post-coital contraception in the United States are limited experience among practitioners and lack of awareness and accessibility among patients. Analogous to a </span>fire extinguisher in homes, emergency contraception requires immediate access for success. There is a nationwide campaign, supported by major national medical organizations, to increase physician acceptability and to make hormonal emergency contraception available over-the-counter, thereby increasing visibility and patient convenience. Until the availability improves, it is prudent for physicians to prescribe emergency contraception as well as provide prevention counseling during routine visits.</span></p></div>","PeriodicalId":80301,"journal":{"name":"Primary care update for Ob/Gyns","volume":"10 6","pages":"Pages 284-287"},"PeriodicalIF":0.0000,"publicationDate":"2003-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1068-607X(03)00069-6","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary care update for Ob/Gyns","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1068607X03000696","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
The American College of Obstetricians and Gynecologists defines emergency contraception, also known as post-coital contraception and the “morning after pill,” as “a therapy for women who experience an act of unprotected sexual intercourse.” It has been estimated that post-coital contraception could reduce the number of unintended pregnancies by 2 million and the number of induced abortions by 1 million. Several methods of emergency contraception are widely accepted including an estrogen-progestin combination, progestin only, mifepristone (RU486), and the copper intrauterine device (IUD). The major side effects of post-coital contraception include nausea, vomiting, and menstrual cycle abnormalities. Currently, the biggest obstacles to post-coital contraception in the United States are limited experience among practitioners and lack of awareness and accessibility among patients. Analogous to a fire extinguisher in homes, emergency contraception requires immediate access for success. There is a nationwide campaign, supported by major national medical organizations, to increase physician acceptability and to make hormonal emergency contraception available over-the-counter, thereby increasing visibility and patient convenience. Until the availability improves, it is prudent for physicians to prescribe emergency contraception as well as provide prevention counseling during routine visits.
美国妇产科医师学会(American College of Obstetricians and Gynecologists)将紧急避孕(也称为性交后避孕和“事后避孕药”)定义为“一种针对经历无保护性交行为的女性的治疗方法”。据估计,性交后避孕可使意外怀孕人数减少200万,人工流产人数减少100万。几种紧急避孕方法被广泛接受,包括雌激素-黄体酮联合用药、仅使用黄体酮、米非司酮(RU486)和铜宫内节育器(IUD)。性交后避孕的主要副作用包括恶心、呕吐和月经周期异常。目前,在美国,性后避孕的最大障碍是从业人员经验有限,患者缺乏意识和可及性。类似于家里的灭火器,紧急避孕需要立即获得成功。在主要国家医疗组织的支持下,开展了一项全国范围的运动,以提高医生的接受程度,并使激素紧急避孕措施成为非处方药品,从而提高知名度,为患者提供便利。在可用性得到改善之前,医生应谨慎地开紧急避孕处方,并在常规就诊期间提供预防咨询。